IL179873A0 - Methods of treatment of endobronchial infections - Google Patents

Methods of treatment of endobronchial infections

Info

Publication number
IL179873A0
IL179873A0 IL179873A IL17987306A IL179873A0 IL 179873 A0 IL179873 A0 IL 179873A0 IL 179873 A IL179873 A IL 179873A IL 17987306 A IL17987306 A IL 17987306A IL 179873 A0 IL179873 A0 IL 179873A0
Authority
IL
Israel
Prior art keywords
treatment
methods
endobronchial infections
endobronchial
infections
Prior art date
Application number
IL179873A
Other versions
IL179873A (en
Original Assignee
Nektar Therapeutics
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics, Novartis Vaccines & Diagnostic filed Critical Nektar Therapeutics
Publication of IL179873A0 publication Critical patent/IL179873A0/en
Publication of IL179873A publication Critical patent/IL179873A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL179873A 2004-06-18 2006-12-06 Use of tobramycin for preparation of a medicament for treating endobronchial infections in a cystic fibrosis patient and compositions and kits comprising it IL179873A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18
PCT/US2005/021952 WO2006002178A1 (en) 2004-06-18 2005-06-20 Methods of treatment of endobronchial infections

Publications (2)

Publication Number Publication Date
IL179873A0 true IL179873A0 (en) 2007-05-15
IL179873A IL179873A (en) 2014-09-30

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179873A IL179873A (en) 2004-06-18 2006-12-06 Use of tobramycin for preparation of a medicament for treating endobronchial infections in a cystic fibrosis patient and compositions and kits comprising it

Country Status (25)

Country Link
US (3) US20080214481A1 (en)
EP (1) EP1765288B1 (en)
JP (3) JP2008503500A (en)
KR (2) KR20070026604A (en)
CN (1) CN101014320B (en)
AU (1) AU2005258078B2 (en)
BR (1) BRPI0512146A (en)
CA (1) CA2570976C (en)
DK (1) DK1765288T3 (en)
EC (1) ECSP077182A (en)
ES (1) ES2399279T3 (en)
HR (1) HRP20130076T1 (en)
IL (1) IL179873A (en)
MA (1) MA28740B1 (en)
MX (1) MXPA06014567A (en)
NO (1) NO338799B1 (en)
NZ (1) NZ552047A (en)
PL (1) PL1765288T3 (en)
PT (1) PT1765288E (en)
RU (1) RU2389477C2 (en)
SG (1) SG153833A1 (en)
SI (1) SI1765288T1 (en)
TN (1) TNSN06420A1 (en)
WO (1) WO2006002178A1 (en)
ZA (1) ZA200700420B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005865A (en) * 2001-12-19 2004-09-13 Nektar Therapeutics Pulmonary delivery of aminoglycosides.
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
EP2083833B1 (en) * 2006-10-11 2018-01-24 Laboratoires SMB SA Pharmaceutical anti-infective composition for inhalation.
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
AU2009246217B2 (en) 2008-05-15 2013-01-10 Novartis Ag Pulmonary delivery of a fluoroquinolone
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
AU2010253776B2 (en) * 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP3001194B1 (en) 2009-08-31 2019-04-17 Abbott Diabetes Care, Inc. Medical devices and methods
UA107095C2 (en) * 2009-12-14 2014-11-25 ANTIBIOTIC MICROPARTICLES FOR INHALATION
ES2881798T3 (en) 2010-03-24 2021-11-30 Abbott Diabetes Care Inc Medical device inserters and medical device insertion and use procedures
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
JP2014523909A (en) 2011-07-12 2014-09-18 カーディアス ファーマ コーポレイション Formulation and method and system of amikacin and fosfomycin combination for the treatment of ventilator-associated pneumonia (VAP) and ventilator-associated trachea (VAT) bronchitis
FI3300658T3 (en) 2011-12-11 2024-03-01 Abbott Diabetes Care Inc Analyte sensor methods
WO2014055456A1 (en) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Medical device insertion indicators
CN102949379B (en) * 2012-11-14 2014-11-05 中山大学 Netilmicin sulfate inhalation powder and preparation method thereof
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
AU2016260547B2 (en) 2015-05-14 2020-09-03 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CN115444410A (en) 2017-01-23 2022-12-09 雅培糖尿病护理公司 Applicator and assembly for inserting an in vivo analyte sensor
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2224175B1 (en) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (en) 1974-07-15 1977-07-20 Isf Spa APPARATUS FOR INHALATIONS
SE438261B (en) 1981-07-08 1985-04-15 Draco Ab USE IN A DOSHALATOR OF A PERFORED MEMBRANE
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (en) 1985-04-12 1987-02-09 Draco Ab INDICATOR DEVICE WITH A DOSAGE DEVICE FOR MEDICINAL PRODUCTS
IT1228459B (en) 1989-02-23 1991-06-19 Phidea S R L INHALER WITH REGULAR AND COMPLETE EMPTYING OF THE CAPSULE.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (en) 1990-07-16 1994-06-10 Promo Pack Sa MULTI-DOSE INHALER FOR POWDER MEDICATIONS
JP3230056B2 (en) 1991-07-02 2001-11-19 インヘイル・インコーポレーテッド Device for forming an aerosolized dose of a drug
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (en) 1993-10-01 1999-12-30 Astra Ab Methods and devices that promote increased particle aggregation
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
CA2190502A1 (en) 1994-05-18 1995-11-23 Robert M. Platz Methods and compositions for the dry powder formulation of interferons
ES2302332T3 (en) 1994-09-21 2008-07-01 Nektar Therapeutics APPARATUS AND METHODS TO DISPERSE DRY POWDER DRUGS.
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
ATE287703T1 (en) 1995-04-14 2005-02-15 Nektar Therapeutics POWDERED PHARMACEUTICAL FORMULATIONS WITH IMPROVED DISPERSIBILITY
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
CZ20012147A3 (en) * 1998-12-17 2003-01-15 Chiron Corporation Pharmaceutical preparation in the form of dry powder or atomized aerosol composition for treating chronic bronchitis
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
AU763041B2 (en) 1999-08-25 2003-07-10 Alkermes, Inc. Modulation of release from dry powder formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
JP2004534763A (en) 2001-05-18 2004-11-18 カイロン コーポレイション Methods and unit dose formulations for inhaled administration of aminoglycoside antibiotics
DE10131917A1 (en) 2001-07-02 2003-01-23 Infineon Technologies Ag Method for producing a step-like structure on a substrate
EP1443996B1 (en) 2001-11-14 2011-05-18 Novartis AG Aerosolization apparatus comprising connectable body and endpiece
WO2003041777A1 (en) 2001-11-14 2003-05-22 Nektar Therapeutics Aerosolization device with improved endpiece connection
MXPA04005865A (en) 2001-12-19 2004-09-13 Nektar Therapeutics Pulmonary delivery of aminoglycosides.
US8777011B2 (en) 2001-12-21 2014-07-15 Novartis Ag Capsule package with moisture barrier
US20040025876A1 (en) 2002-05-07 2004-02-12 Danforth Miller Capsules for dry powder inhalers and methods of making and using same
CN1493297A (en) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 Nebcin inhalation powder mist agent and its preparation method

Also Published As

Publication number Publication date
AU2005258078A1 (en) 2006-01-05
US20120148641A1 (en) 2012-06-14
KR20120131245A (en) 2012-12-04
JP2008503500A (en) 2008-02-07
TNSN06420A1 (en) 2008-02-22
NO338799B1 (en) 2016-10-24
ES2399279T3 (en) 2013-03-27
CN101014320A (en) 2007-08-08
RU2007101906A (en) 2008-07-27
EP1765288A4 (en) 2009-05-13
DK1765288T3 (en) 2013-02-11
AU2005258078B2 (en) 2010-09-30
RU2389477C2 (en) 2010-05-20
EP1765288B1 (en) 2012-11-07
JP2012107047A (en) 2012-06-07
ECSP077182A (en) 2007-05-30
CA2570976C (en) 2013-08-13
US20110097412A1 (en) 2011-04-28
MA28740B1 (en) 2007-07-02
SI1765288T1 (en) 2013-02-28
WO2006002178A1 (en) 2006-01-05
US20080214481A1 (en) 2008-09-04
JP2013056947A (en) 2013-03-28
BRPI0512146A (en) 2008-02-12
CN101014320B (en) 2011-05-18
IL179873A (en) 2014-09-30
PT1765288E (en) 2013-01-29
MXPA06014567A (en) 2007-07-24
CA2570976A1 (en) 2006-01-05
KR20070026604A (en) 2007-03-08
US8664187B2 (en) 2014-03-04
ZA200700420B (en) 2008-05-28
NZ552047A (en) 2009-11-27
SG153833A1 (en) 2009-07-29
NO20070253L (en) 2007-03-13
EP1765288A1 (en) 2007-03-28
HRP20130076T1 (en) 2013-03-31
PL1765288T3 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
IL179873A0 (en) Methods of treatment of endobronchial infections
PL1951272T3 (en) Use of lactobacillus for treatment of virus infections
HK1134679A1 (en) Compositions and methods for the treatment of infections
IL188746A0 (en) Treatment of cancer
EP1838330A4 (en) Treatment of solid cancers
ZA200704392B (en) Antibiotic combinations for providing total solution to the treatment of infections
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
GB0513096D0 (en) Treatment of microbial infections
IL182993A0 (en) Treatment of mastitis
IL180459A0 (en) Treatment of bacterial infections
ZA200704775B (en) Compositions for treatment of ear infections
GB0426196D0 (en) Methods of treatment
LT1951374T (en) Treatment of sub-gingival pocket infections
MY144154A (en) Method of combating infection
GB0408521D0 (en) Treatment of sepsis
GB0512646D0 (en) Treatment of gases
EP1871404A4 (en) Treatment of asthma
HU0400952D0 (en) Treatment of anus-cancer
GB0422012D0 (en) Methods of treatment
GB0511322D0 (en) Treatment of rail
GB0518003D0 (en) Treatment of hepatatis c
GB0522330D0 (en) Method of treatment
GB0518122D0 (en) Treatment of coccidiosis
GB0420429D0 (en) Treatment of coccidiosis
GB0509298D0 (en) Treatment of inflammation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed